Omrix Biopharmaceuticals Inc: Premium Company Profile

Questions: Discounts, Updates etc.

Price: $495.00

Publication Date: 2007-12-25

Order Online Now

People that purchased this report also purchased:

Contact LeadDiscovery

  • If you have questions about this report
  • To find out if you qualify for a discount
  • Want a more up to date version
  • Can't find a report that meets your needs
Search all reports

Keywords:

Boolean terms AND, OR, NOT can be used. Phrases should be entered within quotes. For wildcards use an *

Omrix Biopharmaceuticals's main focus is to discover, develop and commercialize innovative biosurgical and passive immunotherapy products, utilizing its proprietary protein purification technology and manufacturing know-how. The company has two product lines: biosurgical products, that include products that are used for the control of bleeding and passive immunotherapy products.


Scope

  • Contains corporate strategy, value chain presence and SWOT Analysis
  • Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors
  • Includes information on suppliers/ partners, shareholding structure and key employees with biographies


    • Report Highlights
    Omrix Biopharmaceuticals manufactures and develops products in two areas: biosurgery and passive immunotherapy. The company's marketed biosurgical products include Evicel, Quixil and Evithrom. Passive immunotherapy products include IVIG, VIG and HBIG.

    Omrix Biopharmaceuticals's biggest contributor to sales growth out to 2010 will be the sales of Biosurgical products. Revenues from Biosurgical products are expected to increase from $13 million in 2006 to $122 million in 2010, representing an absolute growth of +$109 million during the period.

    Omrix aims to make its biosurgical products and passive immunotherapy products the treatments of choice in their respective therapeutic areas. The company also aims to have strategic collaborations partnerships that allow the company to diversify its development risk and develop multiple products which will be a key to its success in these areas.


    Reasons to Purchase

  • Access all the important information and analysis on the company in a single report
  • Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain
  • Gain access to company's adjusted five year financial data along with key ratios and market capitalization

    • Table of Contents

    Other users found this report page using the following search terms: omrix biopharmaceuticals evicel quixil sales hbig competition evithrom biosurgical uk

    If you can't find a report that meets your needs contact LeadDiscovery. We are one of the few report providers with extensive drug development experience and we frequently use this knowledge to help clients source the most appropriate reports or produce reports for them from scratch.


    Refund and Cancellation Policy: The descriptions of the products and services sold on LeadDiscovery.co.uk are as complete and accurate as possible, and customers are encouraged to read all available information about a product before placing an order. Due to the nature of the information being sold, orders for reports cannot be canceled.